• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Stevanato Group expands corporate headquarters

November 17, 2021 By Sean Whooley

stevanato Group Italy Facility
[Image from Stevanato Group]
Stevanato Group (NYSE:STVN) announced today that it expanded its corporate headquarters with a new facility in Italy.

Based in Piombino Dese, Italy, Stevanato Group said the 6,750-square-meter facility will support the optimization of its industrial footprint while advancing operations and growth within the company.

About 2,500 square meters of the facility will be dedicated to increasing production of high-value products, with new glass syringe forming lines devoted to producing EZ-Fill solutions (pre-sterilized drug containment solutions) added to hosting offices, an Italian analytical services site and R&D space, the company said in a news release.

Construction of the new building began in September 2021. Stevanato Group plans to install and validate new lines in the second quarter of 2022 with expectations for beginning industrial production late in the second quarter or early in the third quarter.

The new facility falls in line with Stevanato Group’s 2020-2023 industrial plan, as the company recently operationalized two additional lines for EZ-Fill vials and syringes manufacturing in Italy with plans to add two more lines devoted to EZ-Fill syringes and one for Alba syringes.

The company announced plans last month to construct a facility in Fishers, Indiana, to be closer to its North America-based pharmaceutical customers and provide an additional supply source for its mission-critical products.

“We are very proud of the global growth and evolution that Stevanato Group has achieved over the recent years, and we are always exploring new opportunities and ways to meet our customers’ needs,” Stevanato Group CEO Franco Moro said in the news release. “Further increasing our production capabilities here at home through this new space we expect to be able to bridge capacity demands while our exciting projects in the U.S. and China are underway.”

Filed Under: Auto-injectors, Business/Financial News, Drug-Device Combinations, Featured, Pharmaceuticals Tagged With: Stevanato Group

IN CASE YOU MISSED IT

  • BD files patent infringement lawsuit against Baxter over infusion pump tech
  • Tandem Diabetes Care subsidiary earns new FDA clearance for insulin infusion set
  • Glucotrack can proceed with long-term glucose monitor study in Australia
  • Dexcom promotes Jake Leach to president role
  • Roche invests $550M to make Indianapolis a CGM manufacturing hub

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS